SynthesisFrontiers in oncology2020

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data.

Francesco Giovinazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.